home / press / releases

Menu
  • Search all tables

releases: https://lee.house.gov/news/press-releases/barbara-lee-congratulates-emeryville-company-on-hhs-award-novartis-vaccines-and-diagnostics-gets-220-million-for-influenza-research

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://lee.house.gov/news/press-releases/barbara-lee-congratulates-emeryville-company-on-hhs-award-novartis-vaccines-and-diagnostics-gets-220-million-for-influenza-research Barbara Lee Congratulates Emeryville Company on HHS Award Novartis Vaccines and Diagnostics Gets $220 Million for Influenza Research 2006-05-04 2006 2006-05 Democrat House CA Barbara Lee L000551 lee.house.gov     legacy 05.04.06 Barbara Lee Congratulates Emeryville Company on HHS Award Novartis Vaccines and Diagnostics Gets $220 Million for Influenza Research (Washington, DC) Congresswoman Barbara Lee (D-Oakland) congratulated Emeryville-based Novartis Vaccines and Diagnostics (formerly Chiron) for being selected as the recipient of a $220 million award from the Department of Health and Human Services (HHS) for the development of cell-based production technologies for influenza vaccines. We need to be prepared for an influenza pandemic, and I'm proud that our district has been selected to help our nation meet that challenge, said Lee. The award was one of five totaling more than $1 billion announced today by HHS Secretary Mike Leavitt as part of the effort to produce flu vaccines more quickly, and produce them in the United States. ### Next Article 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.842ms · Data license: MIT · Data source: dwillis/congress-press